Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SMR | Class A Common Stock | Options Exercise | $78.6K | +12.3K | +157.42% | $6.41 | 20.1K | Feb 13, 2023 | Direct | F1 |
transaction | SMR | Class A Common Stock | Options Exercise | $37K | +5.77K | +28.77% | $6.41 | 25.8K | Feb 13, 2023 | Direct | F1 |
transaction | SMR | Class A Common Stock | Options Exercise | $26.8K | +2.82K | +55.86% | $9.53 | 7.85K | Feb 13, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SMR | Employee Stock Option (right to buy) | Options Exercise | $0 | -12.3K | -70.84% | $0.00 | 5.05K | Feb 13, 2023 | Class A Common Stock | 12.3K | $6.41 | Direct | F2, F3 |
transaction | SMR | Employee Stock Option (right to buy) | Options Exercise | $0 | -5.77K | -33.33% | $0.00 | 11.5K | Feb 13, 2023 | Class A Common Stock | 5.77K | $6.41 | Direct | F2, F4 |
transaction | SMR | Employee Stock Option (right to buy) | Options Exercise | $0 | -2.82K | -27.09% | $0.00 | 7.58K | Feb 13, 2023 | Class A Common Stock | 2.82K | $9.53 | Direct | F5 |
Id | Content |
---|---|
F1 | The number of Acquired Securities and Amount of Securities Beneficially Owned following the transaction were inaccurately reported on Form 4 filed February 15, 2023. |
F2 | The Number of Derivatives Disposed of and Number of Derivative Securities Beneficially owned following reported transaction were inaccurately reported on Form 4 filed February 15, 2022. |
F3 | The option became exercisable for 25% of the shares on April 1, 2021, and for 1/48th of the shares at the end of each one-month period thereafter, so that the option will become fully exercisable on April 1, 2024. |
F4 | The option became exercisable for 25% of the shares on November 1, 2022, and for 1/48th of the shares at the end of each one-month period thereafter, so that the option will become fully exercisable on November 1, 2025. |
F5 | The option became exercisable for 25% of the shares on January 4, 2023, and for 1/48th of the shares at the end of each one-month period thereafter, so that the option will become fully exercisable on January 4, 2026. |